# Processa Pharmaceuticals, Inc.: Form 8-K, filed Oct 30, 2017

- Company: [Processa Pharmaceuticals, Inc.](/companies/pcsa.md) (CIK 1533743)
- Form: 8-K
- Filed: 2017-10-30
- Accepted by EDGAR: Oct 30, 2017, 17:27 ET
- Period: 2017-10-23
- Accession: 0001393905-17-000333
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533743/000139390517000333/hwux_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533743/000139390517000333/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533743/000139390517000333/hwux_8k.htm

Filed Oct 30, 2017.
Source: SEC EDGAR, the filing index for accession 0001393905-17-000333. Last ingested by Listed: Nov 14, 2026, 23:30 ET. No prices; not investment advice.
